Effect of Phellodendron chinense Schneid Extract on Chronic Bacterial Prostatitis Induced by Chlamydia in Rats by Sun, Limei et al.
Sun et al 
Trop J Pharm Res, March 2016; 15(3): 507  
 
Tropical Journal of Pharmaceutical Research March 2016; 15 (3): 507-511 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v15i3.11 
Original Research Article 
 
 
Effect of Phellodendron chinense Schneid Extract on 
Chronic Bacterial Prostatitis Induced by Chlamydia in Rats 
 
Limei Sun1, Li Zhou2, Jing Tian1 and Shuyun Zheng1* 
1Department of Dermatology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, 2Department of Urology, 
The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, Heilongjiang Province, China 
 
*For correspondence: Email: zhengshuyun133494@163.com; Tel: +86 0451-85553842 
 
Received: 15 May 2015        Revised accepted: 6 February 2016 
 
Abstract 
Purpose: To explore the effects of Phellodendron chinense Schneid (PCS) extract on chlamydia-
induced chronic bacterial prostatitis (CBP). 
Methods: Sixty 8-week-old male Sprague-Dawley rats were used in this study. Prostate index (PI) and 
prostate specific antigen (PSA) were determined after 4 weeks of oral administration of PCS extract (80, 
160 or 320 mg/kg) or tetracycline (80 mg/kg) and compared to PI and PSA in untreated rats with CBP 
and healthy control rats (n = 10). Chronic inflammatory cell infiltrates, acinar changes, and interstitial 
fibrosis were evaluated by histopathological examination. In addition, pertinent inflammatory factors, 
including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), cyclooxygenase-2 (COX-2), 
prostaglandin E2 (PEG2), transforming growth factor β1 (TGF-β1), and connective tissue growth factor 
(CTGF), were measured in prostate tissues using ELISA kits.  
Results: High doses of PCS (160 and 320 mg/kg) significantly decreased PI and PSA relative to model 
group (p < 0.01). PCS treatment also significantly reduced chronic inflammatory cell infiltrates and 
interstitial fibrosis in prostate tissue of CBP rats. In addition, TNF-α, IL-1β, COX-2, PEG2, TGF-β1, and 
CTGF decreased in PCS-treated rats compared to untreated control (p < 0.01).  
Conclusion: PCS extract has significant anti-inflammatory effects on chlamydia-induced CBP. 
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Epidemiological research in the past decade has 
revealed that prostatitis is a major urological 
health problem [1,2]. There are several causes of 
chronic bacterial prostatitis (CBP); thus, its 
diagnosis and treatment have not yet been 
clearly defined [3].  
 
Oral antibiotics are the typical first-line treatment 
for CBP. However, antibiotics do not efficiently 
penetrate the plasma–prostate barrier [4]. There 
is a need, therefore, to identify alternative 
treatments for CBP. 
 
Phellodendron chinense Schneid (PCS), which is 
also known as huang bai and is widely cultivated 
in southwest China, is one of the 50 fundamental 
herbs of traditional Chinese medicine. PCS has 
immune-modulation [5], anti-tumor [6], and anti-
bacterial [7,8] properties.  
 
The aim of the present study was to evaluate the 
therapeutic effects and mechanisms of action of 
PCS extract on chlamydia-induced CBP.  
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Herbal samples of Phellodendron chinense 
Schneid were collected from Bozhou City, Anhui 
Province in China in May 2014. Taxonomic 
identification of the plant was performed by 
Professor Wuke Wang of Harbin Medical 
University in China. A herbarium specimen (no. 
PCS 201307015) was deposited in the College of 
Pharmacy, Harbin Medical University, China for 
future reference.  
 
The same batch of PCS was dried, first in an 
oven, and then by freeze drying. One gram of 
powder was equivalent to approximately 1.5 g of 
crude sample. The yield was 66.67 %. The 
aqueous extract of PCS was obtained by 
steeping this dried PCS in water for 1 h at 60 oC 




Eight week old male Sprague-Dawley rats (250–
300 g) were provided by the Experimental Animal 
Center of Harbin Province (certificate no. 
SYXK2005-0004). The animals had free access 
to food and water and were allowed to acclimate 
to the laboratory environment for at least 1 week 
prior to the experiments. This study was 
approved by the Animal Care and Use 
Committee of Harbin Medical University 
(approval ref no. 20120805) and was carried out 
in compliance with Directive 2010/63/EU on the 
Handling of Animals Used for Scientific Purposes 
[9]. 
 
The rats were randomly divided into 6 groups of 
10 rats each: healthy group(not have chlamydia-
induced CBP), model group, positive treatment 
group (80 mg/kg tetracycline), and three PCS-
treated groups (80, 160, and 320 mg/kg doses). 
Tetracycline and PCS extract were both 
dissolved in water. Treatments were 
administered orally once per day for 4 weeks. 
 
Chronic bacterial prostatitis model (CBP) 
 
CBP was induced using previously described 
procedures [10]. Briefly, a strain of Chlamydia 
(Z17, O2:K1:H-) was grown overnight at 37 oC in 
a tryptic soy broth (TSB) in a shaker. Cells were 
spun, washed three times, and re-suspended in 
TSB to obtain 108 cells/mL.  
 
Rats were anaesthetized with ether, and the 
genital area was cleaned with 70 % alcohol and 
subsequently catheterized with a lubricated 
sterile polyethylene tube (0.9-mm outer diameter, 
2.5-cm length). An insulin syringe was attached 
to the needle, and 0.2 mL of the bacterial 
suspension containing 1 × 108 colony-forming 
units per mL of chlamydia was injected into the 
prostatic urethra. Anesthesia was maintained for 
1 h to prevent urinary leakage due to movement 
of the rat and to allow a sufficient time for 
bacteria to invade the prostate. 
 
Measurement of prostate index (PI) and 
prostate specific antigen (PSA) 
 
The prostatic index (PI) of all rats was computed 
as prostate weight (mg)/body weight (g). Blood 
was collected by removing the eyeball. The blood 
sample was allowed to clot, and the serum was 
separated at 3500 r/min for 15 min. ELISA kits 
(provided by Shenzhen Xin-Bo-Sheng Biological 
Technology Co Ltd, Shenzhen, China) then were 
used to determine the level of prostate specific 
antigen (PSA). 
 
Measurement of tumor necrosis factor-α 
(TNF-α) and interleukin-1β (IL-1β) 
 
Pro-inflammatory cytokines tumor necrosis 
factor-α (TNF-α) and interleukin-1β (IL-1β) were 
measured in prostate tissue from CBP group and 
PCS-treated groups using commercial ELISA 
assay kits (Shenzhen Xin-Bo-Sheng Biological 
Technology Co Ltd) according to the 
manufacturer’s instructions. Samples and 
standards were run in duplicate and resulting 
data were averaged. Results are expressed in 
pg/mL. 
 
Measurement of PGE2, COX-2, TGF-β1, and 
CTGF 
 
The effects of CBP on prostaglandin E2 (PGE2), 
cyclooxygenase-2 (COX-2), transforming growth 
factor β1 (TGF-β1), and connective tissue growth 
factor (CTGF) levels were measured in prostate 
tissues using commercial ELISA kits (Shenzhen 
Xin-Bo-Sheng Biological Technology Co Ltd). All 
assays were performed in 10 % prostate 
supernatant in accordance with the 
manufacturer’s instructions. Results are 




Prostates were excised and fixed in 4 % 
paraformaldehyde for histopathological studies. 
Sections of prostates were dehydrated by 
ethanol, and 4 - 5 mm sections were cut, stained 
with hematoxylin and eosin, and examined under 
a light microscope (Beijing Olympus Co. Ltd., 
Beijing China). 
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Data are presented as mean ± standard 
deviation (SD), and analyzed by one-way 
analysis of variance (ANOVA) followed by 
Tukey’s multiple comparison test in Statistical 
Package for the Social Sciences software (SPSS 
for Windows, version 16.0, SPSS, Inc., Chicago, 
IL, USA). Differences were considered 




Effect of PCS extract on PI and PSA 
 
The effects of 4 weeks of oral administration of 
PCS extract on PI and PSA levels are 
summarized in Table 1. Compared with healthy 
controls, PI and PSA increased to 2.4 mg/g and 
327.8 pg/mL, respectively (p < 0.01), in the 
Chlamydia-induced CBP group. After treatment 
with PCS extract, PI and PSA significantly 
decreased (p < 0.01). The largest decrease was 
observed in response to the highest dose of PCS 
extract. PI and PSA levels also decreased after 4 
weeks of tetracycline administration (p < 0.01). 
 
Effect of PCS extract on TNF-α and IL-1β 
 
The effects of 4 weeks of oral administration of 
PCS extract on TNF-α and IL-1β levels are 
summarized in Table 2. Compared with healthy 
controls, TNF-α significantly increased in 
Chlamydia-induced CBP rats (p < 0.01). TNF-α 
was significantly decreased by 160 and 320 
mg/kg doses of PCS extract compared with the 
model group (p < 0.05 and p < 0.01, 
respectively). Similarly, IL-1β was significantly 
increased in chlamydia-induced CBP rats 
compared with healthy controls (p < 0.01), and 
significantly decreased by 160 and 320 mg/kg 
doses of PCS extract (p < 0.01). Tetracycline 
also significantly decreased TNF-α and IL-1β 
levels (p < 0.01). 
 
Effect of PCS extract on PGE2, COX-2, TGF-
β1, and CTGF 
 
The effects of 4 weeks of oral administration of 
PCS extract on PGE2, COX-2, TGF-β1, and 
CTGF levels are summarized in Table 3. PGE2, 
COX-2, TGF-β1, and CTGF were all significantly 
increased in chlamydia-induced CBP rats (p < 
0.01). After treatment with PCS, both PGE2 and 
TGF-β1 significantly decreased in a dose-
dependent manner (p < 0.05). Similarly, CTGF 
and COX-2 were both significantly decreased by 
160 and 320 mg/kg doses of PCS extract (p < 
0.01).  Tetracycline also significantly decreased 
PGE2 (p < 0.01), COX-2 (p < 0.05), TGF-β1 (p < 
0.05), and CTGF (p < 0.01) levels. 
 
Table 1: Effect of PCS extract on PI and PSA levels 
 
Group Dose (mg/kg)  PI (mg/g） PSA (pg/mL) 
Healthy — 0.8±0.2** 119.3±10.8** 
Model — 2.4±0.2 327.8±20.5 
Tetracycline 80 1.5±0.4 179.4±15.6** 
PCS-L 80 1.6±0.3 271.6±30.4 
PCS-M 160 1.3±0.2* 178.7±20.8* 
PCS-H 320 1.0±0.1** 149.2±13.5** 
Data are expressed as the mean ± SD; n = 10 in each group; PCS-L = low dose of PCS extract; PCS-M = 
moderate dose of PCS extract; PCS-H = high dose of PCS extract; *p < 0.05，**p < 0.01 vs. model group 
 
Table 2: Effect of PCS extract on TNF-α and IL-1β levels 
 
Group Dose (mg/kg) TNF-α (pg/mL) IL-1β (pg/mL) 
Healthy — 99.6±8.5** 73.6±6.4** 
Model — 158.4±13.2 174.1±12.1 
Tetracycline 80 119.5±7.4** 120.4±11.7** 
PCS-L 80 146.3±15.8 149.7±14.8 
PCS-M 160 131.7±8.2* 122.5±8.7** 
PCS-H 320 122.5±9.3** 98.6±10.3** 
Data are expressed as the mean ± SD (n = 10); PCS-L = low dose of PCS extract; PCS-M = moderate dose of 
PCS extract; PCS-H = high dose of PCS extract; *p < 0.05，**p < 0.01 vs. model group 
 
 
Sun et al 
Trop J Pharm Res, March 2016; 15(3): 510  
 
Table 3: Effect of PCS extract on PGE2, COX-2, TGF-β1, and CTGF levels 
 









Healthy  66.5±3.6** 11.5±1.3** 70.7±4.1** 57.2±3.4** 
Model  126.6±6.7 33.5±3.4 146.2±12.7 117.4±5.8 
Tetracycline 80 85.4±5.9** 15.2±2.8* 110.4±8.6* 89.4±6.1** 
PCS-L 80 102.6±4.8* 26.1±4.3 126.4±9.6* 115.6±7.1 
PCS-M 160 93.4±6.4** 17.1±3.2** 111.6±7.6** 93.3±8.4** 
PCS-H 320 81.4±4.5** 14.5±2.5** 87.5±8.1** 72.4±6.3** 
Data are expressed as the mean ±SD (n = 10); PCS-L = low dose of PCS extract; PCS-M = moderate dose of 
PCS extract; PCS-H = high dose of PCS extract; *p < 0.05，**p < 0.01 vs. model group 
 
 
Figure 1: Effect of PCS extract on the histomorphology of prostate tissues in rats. Hematoxylin and eosin stained 
(x 200) prostate cells in the A: healthy group; B: model group; C: positive group (80 mg/kg tetracycline); D: 80 
mg/kg PCS extract group; E: 160 mg/kg PCS extract group; F: 320 mg/kg PCS extract group; EH = epithelial 




No change in the morphological structure of the 
prostate gland was found in healthy controls 
(Figure 1A). In contrast, severe diffuse chronic 
inflammation characterized by leukocyte 
infiltration and papillary frond protrusion into the 
gland cavities, as well as an increase in prostatic 
epithelial height, were observed in the lateral 
lobe of the prostate in chlamydia-induced CBP 
rats (Figure 1B). However, these changes were 
significantly suppressed in rats administered 
tetracycline or PCS extract, especially at doses 





PCS is a traditional Chinese medicine used for 
the treatment of prostatitis in China. In our study, 
experimental CBP was induced by Chlamydia, 
which was confirmed by increased levels of PI 
and PSA. Four weeks of oral administration of 
PCS extract significantly decreased PI and PSA, 
as well as several inflammatory markers, 
including COX-2, PGE2, TGF-β1, and CTGF. 
Thus, the administration of PCS extract for 4 
weeks significantly inhibited the development of 
chronic inflammation and fibrosis in prostatic 
tissue [11,12]. 
 
IL-1β is a pro-inflammatory cytokine [13], and 
TNF-α is rapidly produced by macrophages in 
response to tissue damage [14]. Studies have 
shown that the activation of transcription factor 
NF-κB by TNF-α is one of several actions of 
TNF-α [15]. Cytokine-based therapies have been 
found to be useful in preventing the progression 
of chronic prostatitis [16]. In the present study, 
increased levels of TNF-α and IL-1β in 
chlamydia-induced CBP rats were suppressed by 
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160 and 320 mg/kg of PCS extract. Similarly, 
increased levels of COX-2 and PGE2 in 
chlamydia-induced CBP rats were reversed by 
PCS treatment. Therefore, the anti-CBP effect of 
PCS extract may be related to its anti-
inflammatory properties. 
 
TGF-β, which is the most extensively studied 
molecule in fibrosis, stimulates the production of 
reactive oxygen species in various types of cells 
[17-19]. In addition, CTGF has been implicated in 
fibroblast proliferation, cellular adhesion, 
angiogenesis, and extracellular matrix synthesis 
[20-22]. Our results indicate that PCS extract 
suppresses CBP-enhanced TGF-β1 expression. 
Our results also suggest that PCS extract 





The results of this study demonstrate that PCS 
has a significant anti-inflammatory effect on 
chronic bacterial prostatitis in rats. Further 
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